Russian MedicineRussian MedicineРоссийский медицинский журнал0869-21062412-9100Eco-Vector7638010.17816/0869-2106-2021-27-2-195-200Case reportsКлинический случайReview ArticleA clinical case of the novel coronavirus (COVID-19) reinfection in a health care workerКлинический случай повторного заражения новой коронавирусной инфекцией COVID-19 медицинского работникаhttps://orcid.org/0000-0002-9176-1889KovtyukhIrina V.КовтюхИрина Владимировна
Russian Federation
ivkovtuh@mail.ruhttps://orcid.org/0000-0002-7846-1611GendlinGennady E.ГендлинГеннадий Ефимович
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

rgmut2@mail.ruhttps://orcid.org/0000-0003-1699-0881NikitinIgor G.НикитинИгорь Геннадиевич
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

igor.nikitin.65@mail.ruKabirovaEkaterina V.КабироваЕкатерина Вячеславовна
Russian Federation
bazamarsa@mail.ruMarkinaOlga Yu.МаркинаОльга Юрьевна
Russian Federation
o.u@gmail.comFederal State Budgetary Institution of Healthcare Central Clinical Hospital of the Russian Academy of SciencesЦентральная клиническая больница Российской академии наукN.I. Pirogov Russian National Research Medical UniversityРоссийский национальный исследовательский медицинский университет имени Н.И. ПироговаCity clinical hospital №24Городская клиническая больница № 24 Департамента здравоохранения г. Москвы150420212721952002207202122072021Copyright ©; 2021, Eco-VectorCopyright ©; 2021, ООО "Эко-Вектор"2021Eco-VectorООО "Эко-Вектор"https://medjrf.com/0869-2106/article/view/76380

The peculiarities of immune responses to a novel coronavirus infection (COVID-19) and the possibility of reinfection due to the variability of humoral immunity are currently under discussion. This article presents a case of COVID-19 reinfection in a health care worker.

Особенности иммунного ответа после перенесенной новой коронавирусной инфекции COVID-19 и возможность повторного инфицирования ввиду вариабельности формирования гуморального иммунитета являются предметом обсуждения в настоящее время. В статье представлен случай повторного заболевания COVID-19 у медицинского работника.

COVID-19reinfectionhumoral immunityCOVID-19реинфекциягуморальный иммунитетRoy S. COVID-19 Reinfection: Myth or Truth? SN Compr Clin Med. 2020:1–4. doi: 10.1007/s42399-020-00335-8Roy S. COVID-19 Reinfection: Myth or Truth? // SN Compr Clin Med. 2020. P. 1–4. doi: 10.1007/s42399-020-00335-8Law SK, Leung AWN, Xu C. Is reinfection possible after recovery from COVID-19? Hong Kong Med J. 2020;26(3):264–265.Law S.K., Leung A.W.N., Xu C. Is reinfection possible after recovery from COVID-19? // Hong Kong Med J. 2020. Vol. 26, N 3. P. 264–265. doi: 10.12809/hkmj208601Falahi S, Kenarkoohi A. COVID-19 reinfection: prolonged shedding or true reinfection? New Microbes New Infect. 2020;38:100812. doi: 10.1016/j.nmni.2020.100812Falahi S., Kenarkoohi A. COVID-19 reinfection: prolonged shedding or true reinfection? // New Microbes New Infect. 2020. Vol. 38, N. P. 100812. doi: 10.1016/j.nmni.2020.100812Khoshkam Z, Aftabi Y, Stenvinkel P, et al. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection. J Adv Res. 2021; 31:49-60. doi: 10.1016/J.jare.2020.12.013Khoshkam Z., Aftabi Y., Stenvinkel P., et al. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection // J Adv Res. 2021. Vol. 31. P. 49–60. doi: 10.1016/j.jare.2020.12.013Kang H, Wang Y, Tong Z, Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: Persistence, sampling issues, or re-infection? J Med Virol. 2020;92(11):2263–2265.Kang H., Wang Y., Tong Z., Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: Persistence, sampling issues, or re-infection? // J Med Virol. 2020. Vol. 92, N 11. P. 2263–2265. doi: 10.1002/jmv.26114SeyedAlinaghi S, Oliaei S, Kianzad S, et al. Reinfection risk of novel coronavirus (COVID-19): A systematic review of current evidence. World J Virol. 2020;9(5):79–90.SeyedAlinaghi S., Oliaei S., Kianzad S., et al. Reinfection risk of novel coronavirus (COVID-19): A systematic review of current evidence // World J Virol. 2020. Vol. 9, N 5. P. 79–90. doi: 10.5501/wjv.v9.i5.79Tao W, Wang X, Zhang G, et al. Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. Protein Cell. 2021;12(3):230–235.Tao W., Wang X., Zhang G., et al. Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection // Protein Cell. 2021. Vol. 12, N 3. P. 230–235. doi: 10.1007/s13238-020-00778-8Wu F, Zhang W, Zhang L, et al. Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again. Br J Hosp Med (Lond). 2020;81(4):1–2.Wu F., Zhang W., Zhang L., et al. Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again // Br J Hosp Med (Lond). 2020. Vol. 81, N 4. P. 1–2. doi: 10.12968/hmed.2020.0156Kang H, Wang Y, Tong Z, Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: Persistence, sampling issues, or re-infection? J Med Virol. 2020;92(11):2263–2265.Kang H., Wang Y., Tong Z., Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: Persistence, sampling issues, or re-infection? // J Med Virol. 2020. Vol. 92, N 11. P. 2263–2265. doi: 10.1002/jmv.26114Piri SM, Edalatfar M, Shool S, et al. A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations. Infect Dis (Lond). 2021;(Jan 28):1–10. doi: 10.1080/23744235.2020.1871066Piri S.M., Edalatfar M., Shool S., et al. A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations // Infect Dis (Lond). 2021. Jan 28. P. 1–10. doi: 10.1080/23744235.2020.1871066Alizargar J. Risk of reactivation or reinfection of novel coronavirus (COVID-19). J Formos Med Assoc. 2020;119(6):1123. doi: 10.1016/j.jfma.2020.04.013Alizargar J. Risk of reactivation or reinfection of novel coronavirus (COVID-19) // J Formos Med Assoc. 2020. Vol. 119, N 6. P. 1123. doi: 10.1016/j.jfma.2020.04.013Gousseff M, Penot P, Gallay L, et al. Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? J Infect. 2020;81(5):816–846.Gousseff M., Penot P., Gallay L., et al. Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? // J Infect. 2020. Vol. 81, N 5. P. 816–846. doi: 10.1016/j.jinf.2020.06.073Arafkas M, Khosrawipour T, Kocbach P, et al. Current meta-analysis does not support the possibility of COVID-19 reinfections. J Med Virol. 2021;93(3):1599–1604.Arafkas M., Khosrawipour T., Kocbach P., et al. Current meta-analysis does not support the possibility of COVID-19 reinfections // J Med Virol. 2021. Vol. 93, N 3. P. 1599–1604. doi: 10.1002/jmv.26496Madan M, Kunal S. COVID-19 reinfection or relapse: an intriguing dilemma. Clin Rheumatol. 2020;39(11):3189. doi: 10.1007/s10067-020-05427-3Madan M., Kunal S. COVID-19 reinfection or relapse: an intriguing dilemma // Clin Rheumatol. 2020. Vol. 39, N 11. P. 3189. doi: 10.1007/s10067-020-05427-3He F, Luo Q, Lei M, et al. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review. Clin Rheumatol. 2020;39(9):2803–2810.He F., Luo Q., Lei M., et al. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review // Clin Rheumatol. 2020. Vol. 39, N 9. P. 2803–2810. doi: 10.1007/s10067-020-05230-0Jabbari P, Rezaei N. With Risk of Reinfection, Is COVID-19 Here to Stay? Disaster Med Public Health Prep. 2020;14(4):e33. doi: 10.1017/dmp.2020.274Jabbari P., Rezaei N. With Risk of Reinfection, Is COVID-19 Here to Stay? // Disaster Med Public Health Prep. 2020. Vol. 14, N 4. P. e33. doi: 10.1017/dmp.2020.274Parry J. Covid-19: Hong Kong scientists report first confirmed case of reinfection. BMJ. 2020;370:m3340. doi: 10.1136/bmj.m3340Parry J. Covid-19: Hong Kong scientists report first confirmed case of reinfection // BMJ. 2020. Vol. 370, N. P. m3340. doi: 10.1136/bmj.m3340West J, Everden S, Nikitas N. A case of COVID-19 reinfection in the UK. Clin Med (Lond). 2021;21(1):e52-e53. doi: 10.7861/clinmed.2020-0912West J., Everden S., Nikitas N. A case of COVID-19 reinfection in the UK // Clin Med (Lond). 2021. Vol. 21, N 1. P. e52-e53. doi: 10.7861/clinmed.2020-0912Iwasaki A. What reinfections mean for COVID-19. Lancet Infect Dis. 2021;21(1):3–5.Iwasaki A. What reinfections mean for COVID-19 // Lancet Infect Dis. 2021. Vol. 21, N 1. P. 3–5. doi: 10.1016/s1473-3099(20)30783-0Nachmias V, Fusman R, Mann S, Koren G. The first case of documented Covid-19 reinfection in Israel. IDCases. 2020;22:e00970. doi: 10.1016/j.idcr.2020.e00970Nachmias V., Fusman R., Mann S., Koren G. The first case of documented Covid-19 reinfection in Israel // IDCases. 2020. Vol. 22. P. e00970. doi: 10.1016/j.idcr.2020.e00970Duggan NM, Ludy SM, Shannon BC, et al. Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results. Am J Emerg Med. 2021;39:256 e251-256 e253. doi: 10.1016/j.ajem.2020.06.079Duggan N.M., Ludy S.M., Shannon B.C., et al. Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results // Am J Emerg Med. 2021. Vol. 39. P. 256 e251-256 e253. doi: 10.1016/j.ajem.2020.06.079Bonifacio LP, Pereira APS, Araujo D, et al. Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil. Rev Soc Bras Med Trop. 2020;53:e20200619. doi: 10.1590/0037-8682-0619-2020Bonifacio L.P., Pereira A.P.S., Araujo D., et al. Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil // Rev Soc Bras Med Trop. 2020. Vol. 53. P. e20200619. doi: 10.1590/0037-8682-0619-2020Pal R, Banerjee M. Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19? Prim Care Diabetes. 2021;15(1):18–20.Pal R., Banerjee M. Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19? // Prim Care Diabetes. 2021. Vol. 15, N 1. P. 18–20. doi: 10.1016/j.pcd.2020.08.002Torres DA, Ribeiro L, Riello A, et al. Reinfection of COVID-19 after 3 months with a distinct and more aggressive clinical presentation: Case report. J Med Virol. 2021;93(4):1857–1859.Torres D.A., Ribeiro L., Riello A., et al. Reinfection of COVID-19 after 3 months with a distinct and more aggressive clinical presentation: Case report // J Med Virol. 2021. Vol. 93, N 4. P. 1857–1859. doi: 10.1002/jmv.26637Azam M, Sulistiana R, Ratnawati M, et al. Recurrent SARS-CoV-2 RNA positivity after COVID-19: a systematic review and meta-analysis. Sci Rep. 2020;10(1):20692. doi: 10.1038/s41598-020-77739-yAzam M., Sulistiana R., Ratnawati M., et al. Recurrent SARS-CoV-2 RNA positivity after COVID-19: a systematic review and meta-analysis // Sci Rep. 2020. Vol. 10, N 1. P. 20692. doi: 10.1038/s41598-020-77739-y